Aptatek Biosciences Wins “Best of the Best” at Year-End 1st Pitch Life Science Competition
06 janv. 2020 09h35 HE
|
Mid Atlantic Bio Angels
NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Aptatek Biosciences (www.aptatek.com) which is developing a digital at-home health-maintenance system...
Ancilia, Inc. Wins “Best in Show” at New York City 1st Pitch Life Science Competition
12 nov. 2019 09h35 HE
|
Mid Atlantic Bio Angels
NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Ancilia, Inc., which is developing therapies to specifically target the viral components of the gut...
Aptatek Biosciences Wins “Best in Show” at Philadelphia 1st Pitch Life Science Competition
11 nov. 2019 09h35 HE
|
Mid Atlantic Bio Angels
PHILADELPHIA, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Aptatek Biosciences (www.aptatek.com) which is developing a digital at-home health-maintenance...
Applied Glycan Technologies, Inc. Wins “Best in Show” at 1st Pitch Life Science Competition
21 juin 2019 11h18 HE
|
Mid Atlantic Bio Angels
NEW YORK, June 21, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Applied Glycan Technologies, Inc. (http://www.appliedglycan.com), which is developing a topical...
BrachyThermix Wins “Best in Show” at 1st Pitch Life Science Philadelphia Competition
17 avr. 2019 09h35 HE
|
Mid Atlantic Bio Angels
PHILADELPHIA, April 17, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that BrachyThermix, which has developed a medical device to improve outcomes of cancer surgery...
Handii 3D Wins “Best in Show” at 1st Pitch Life Science Competition
05 avr. 2019 09h35 HE
|
Mid Atlantic Bio Angels
NEW YORK, April 05, 2019 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Handii 3D, which is developing hand and upper extremity splints for cerebral palsy patients, was...
Mid Atlantic Bio Angels Members and Its Closed-End Investment Pool II Makes Investment in Healionics Corporation
22 févr. 2019 09h35 HE
|
Mid Atlantic Bio Angels
NEW YORK, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that its previously announced, second closed-end investment pool (Pool II) solely funded by current, active...
Mid Atlantic Bio Angels Introduces “Sidecar Fund” for Non-Members to Participate in MABA Investments
29 janv. 2019 09h35 HE
|
Mid Atlantic Bio Angels
NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announced today that it has formed a “sidecar” fund (https://sidecarfund.bioangels.net/) allowing accredited investors who...
Avisi Technologies, LLC Wins “Best of the Best” at Mid Atlantic Bio Angels’ Year-End 1st Pitch Life Science Competition
17 déc. 2018 09h40 HE
|
Mid Atlantic Bio Angels
NEW YORK, Dec. 17, 2018 (GLOBE NEWSWIRE) -- Mid-Atlantic Bio Angels (MABA) announces today that Avisi Technologies, LLC, which develops an eye implant for glaucoma treatment, was named “Best of the...
Mid Atlantic Bio Angels Invests in Salarius Pharmaceuticals
30 nov. 2018 09h35 HE
|
Mid Atlantic Bio Angels
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Mid Atlantic Bio Angels (MABA) announces today that it has made an investment in Houston-based Salarius Pharmaceuticals, which is developing epigenetic...